Company Data

Talphera Inc.

Ticker
TLPH
Current Price
$0.6005 -1.88%
Market Cap
$10.2M
Price Target
Refer to Report
Volume
48.1K
52wk Range
$0.501 - $1.5
Advanced Market Data

Overview

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company’s products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy